Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event By: ACCESSWIRE August 15, 2024 at 11:00 AM EDT NEW YORK, NY / ACCESSWIRE / August 15, 2024 / CoCrystal Pharma (NASDAQ:COCP), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses and noroviruses, announces that management will present a company overview at the virtual Investor Summit Microcap Forum being held Tuesday, August 20, 2024. Management will be available for 1-on-1 meetings throughout the day. Qualified investors can register here to view the live presentation and to ask questions. Event: Q3 Investor SummitDate: August 20th, 2024Presentation Time: 9:00 a.m. ET (6:00 a.m. PT)Location: WEBCAST LINK The theme is 50 micro-cap companies with a catalyst and/or strong performance in the current market. Take a deep dive with the best Investors in MicroCap Live Q & A Complimentary to Qualified Investors. Please REGISTER HERE. About Cocrystal PharmaCocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com. About the Investor Summit The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015. Contact:Fred Rockwellfred@investorsummitgroup.com Investor Summit Group SOURCE: CoCrystal Pharma View the original press release on accesswire.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event By: ACCESSWIRE August 15, 2024 at 11:00 AM EDT NEW YORK, NY / ACCESSWIRE / August 15, 2024 / CoCrystal Pharma (NASDAQ:COCP), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses and noroviruses, announces that management will present a company overview at the virtual Investor Summit Microcap Forum being held Tuesday, August 20, 2024. Management will be available for 1-on-1 meetings throughout the day. Qualified investors can register here to view the live presentation and to ask questions. Event: Q3 Investor SummitDate: August 20th, 2024Presentation Time: 9:00 a.m. ET (6:00 a.m. PT)Location: WEBCAST LINK The theme is 50 micro-cap companies with a catalyst and/or strong performance in the current market. Take a deep dive with the best Investors in MicroCap Live Q & A Complimentary to Qualified Investors. Please REGISTER HERE. About Cocrystal PharmaCocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com. About the Investor Summit The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015. Contact:Fred Rockwellfred@investorsummitgroup.com Investor Summit Group SOURCE: CoCrystal Pharma View the original press release on accesswire.com
NEW YORK, NY / ACCESSWIRE / August 15, 2024 / CoCrystal Pharma (NASDAQ:COCP), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses and noroviruses, announces that management will present a company overview at the virtual Investor Summit Microcap Forum being held Tuesday, August 20, 2024. Management will be available for 1-on-1 meetings throughout the day. Qualified investors can register here to view the live presentation and to ask questions. Event: Q3 Investor SummitDate: August 20th, 2024Presentation Time: 9:00 a.m. ET (6:00 a.m. PT)Location: WEBCAST LINK The theme is 50 micro-cap companies with a catalyst and/or strong performance in the current market. Take a deep dive with the best Investors in MicroCap Live Q & A Complimentary to Qualified Investors. Please REGISTER HERE. About Cocrystal PharmaCocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com. About the Investor Summit The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015. Contact:Fred Rockwellfred@investorsummitgroup.com Investor Summit Group SOURCE: CoCrystal Pharma View the original press release on accesswire.com